[Transfer] "Secretary of the Beauty" was investigated, and the annual salary exceeded the chairman

[Transfer] "Secretary of the Beauty" was investigated, and the annual salary exceeded the chairman

Source: Siqi Club/Cantaloupe

Recently, Watson Biological Announcement stated that Zhang Li, secretary of the company's board of directors, was investigated by the Wenshan Premier Committee of Yunnan Province for personal reasons. During Zhang Li's restrictions, the chairman Li Yunchun was responsible for the secretary of the board of directors. Except for Zhang Li, all other senior managers of the company fulfill their duties normally, and all operations and management work is launched normally.

Why was Zhang Li's restrictions by the Wenshan Premier Supervision Committee? Watson Biological said in the announcement that the company will continue to pay attention to the follow -up situation of the above matters.

The tax earlier was nearly 3 million previous year

Public information shows that Zhang Li is 45 years old. In 2017, he was nominated by Li Yunchun in 2017 and served as secretary in Watson Biology. At present, she holds 1.0755 million shares of Watson Bio, and calculated at the closing price of 41.38 yuan per share on September 6, and her stock market value exceeds 44 million yuan. In 2021, Zhang Li's annual salary of 2.9918 million yuan was higher than the chairman Li Yunchun's annual salary. This phenomenon is rare in A -share listed companies.

Source: Watson Biological Report 2021 Annual Report

It is worth mentioning that on December 5, 2018, Zhang Li had been taken out by the Yunnan Securities Regulatory Bureau for violations of information disclosure. The reason is that the performance data of Watson Biological Existence in 2017 The performance data disclosed in the preview of the performance forecasts appeared in major differences and amounts of the nature and amount of the performance, Shandong Shijie's second -phase equity transfer payment was overdue, and the company's major shareholders had not disclosed the pledge of equity. Among them, Zhang Li was identified as the main responsibility for the first and second issues.

In fact, before serving as the secretary of the Watson Biological Biological Biological Biological Biological Biological Biological Biological Biological Biological System, Zhang Li has worked in Yunnan's state -owned assets system for a long time. Assistant General Manager of Limited and Deputy General Manager of Yunnan World Expo Scenic Area Investment Management Co., Ltd..

In 2017, when Zhang Li was hired as the Secretary of Watson Bio, the largest shareholder of Watson Bio was Yunnan Industrial Investment Holding Group, a subsidiary of Yunnan State -owned Assets Supervision and Administration Commission.

The recent trend is sluggish

Watson Biological is the first company listed on the China GEM in Yunnan Province. It is in the leading position of the industry in the field of biotechnology drugs represented by new vaccines.

In the first half of 2022, Watson's biological operating income was 2.348 billion, an increase of 73.96%year -on -year; net profit was 421 million, a year -on -year increase of 31.90%. In the second quarter, net profit increased by 890.12%month -on -month.

Regarding the reasons for the growth of operating income, Watson Bio said that it was mainly due to the increase in sales volume of 13 -valent pneumonia and the increase in the sales volume of new HPV vaccines in the company. It should be pointed out that 13 -valent pneumococcal polysaccharides are the first domestic vaccine to develop and produce and produce in China, and it is also the second product in the world.

In March of this year, Watson Biological Two -valent HPV vaccine was approved, and the number of vaccine products listed on the company reached 8 (12 product regulations).

In addition, according to the INSIGHT database, there are still 5 new crown vaccines in Watson. The technical route covers the reorganized new crown virus protein vaccine, adenovirus vaccine, and mRNA vaccine; Vaccine developed by mutant plants.

Nevertheless, the stock price of Watson's biology has still fallen endlessly. Since the peak of 87.28 yuan/share on August 30 last year, a continuous band -type decline has occurred. As of the close of September 6, Watson Biological stock price closed at 41.38 yuan/share, with the latest market value of 66.29 billion yuan. In the past year, the company's stock price has fallen by more than 50 %.

Disclaimer: This article is the content of Yaozhi.com, and the copyright of the pictures and text belongs to the original author. The purpose of reprinting is to pass more information, which does not represent the viewpoint of this platform. If the content, copyright and other issues are involved in the work, please leave a message on this platform, and we will delete it as soon as possible.

- END -